Kava
Kava, licence 80043886: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- TallGrass Natural Health Ltd.
- NPN or DIN-HM
- 80043886
- Status
- Active licence
- Licence date
- 29 July 2013
- Revision date
- Not provided
- Form
- Gouttes orales
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Piper methysticum Source : Racine Extraction ratio : 1:2.5 Dry plant equivalent : 0.02 g Potency : 1.0 mg Kavalactones | 0.05 mL | Not calculated |
Non-medicinal ingredients
Eau purifiée, Éthanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 75.0 Goutte(s) | 1.0 Tous les jours |
Uses authorised in Canada
Used in herbal medicine to help relieve restlessness. Traditionally used in Herbal Medicine as a diuretic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not take if you have liver disease or suffer from alcoholism. Do not use if you suffer from endogenous depression. Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
May cause gastrointestinal complaints or vivid dreams. Hypersensitivity, ie. Allergy, is known to occur, in which case discontinue use. Extended continuous use may cause a temporary yellowing of the skin, hair, and nails; if this occurs, discontinue use and consult a health care practitioner.
- Précautions et mises en garde
Consult a health care practitioner if sysmptoms persist or worsen. Consult a health care rpactitoner prior to use if you suffer from epilepsy, or if you are using conventional sedative-hypnotics (or natural health products with similar effects) anxiolytics, MAO inhibitorsand other psychopharmacologic agents, levodopa (or other drugs for Parkinson's disease) or antiplatlet agents. Consumption with alcohol or anti-convulsants is not recommended. Excessive use, or use with products that cause drowsiness, may impair your ability to operate a vehicle or use heavy machinery. Discontinue use and consult a heath care practitioner if you develop symptoms that may signal liver problems (E.g unexplained fatigue, abdominal pain, fever, vomiting, dark urine, yellow eyes or skin).
Source
Official Health Canada record, licence 80043886
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.